CURIS, INC. Payments to Acquire Investments
CURIS, INC. (CRIS) reported Payments to Acquire Investments of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2026-03-24
- CURIS, INC. payments to acquire investments for the quarter ending 2025-12-31 was $0.00.
- CURIS, INC. payments to acquire investments for the quarter ending 2025-09-30 was $0.00.
- CURIS, INC. payments to acquire investments for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- CURIS, INC. payments to acquire investments for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- CURIS, INC. payments to acquire investments for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- CURIS, INC. payments to acquire investments for fiscal 2024 was $18.10M, a 74.27% decline from fiscal 2023.
- CURIS, INC. payments to acquire investments for fiscal 2023 was $70.34M, a 13.45% increase from fiscal 2022.
- CURIS, INC. payments to acquire investments for fiscal 2022 was $62.00M, a 33.42% decline from fiscal 2021.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $0.00 derived: sum of 2 quarters · filed 2026-03-24 | $0.00 derived: sum of 3 quarters · filed 2026-03-24 | $0.00 10-K · filed 2026-03-24 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-03-24 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-03-24 | $0.00 derived: sum of 4 quarters · filed 2026-03-24 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-03-24 | $0.00 derived: sum of 3 quarters · filed 2026-03-24 | $7.36M derived: sum of 4 quarters · filed 2026-03-24 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $0.00 derived: sum of 2 quarters · filed 2026-03-24 | $7.36M derived: sum of 3 quarters · filed 2026-03-24 | $18.10M 10-K · filed 2026-03-24 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $7.36M derived: sum of 2 quarters · filed 2025-11-06 | $18.10M 10-Q · filed 2025-11-06 | $23.78M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $7.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $18.10M 10-Q · filed 2025-08-05 | $23.78M derived: sum of 3 quarters · filed 2025-08-05 | $60.10M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $10.74M 10-Q · filed 2025-05-06 | $16.42M derived: sum of 2 quarters · filed 2025-05-06 | $52.74M derived: sum of 3 quarters · filed 2025-05-06 | $63.40M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $5.68M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $42.00M derived: sum of 2 quarters · filed 2025-03-31 | $52.66M derived: sum of 3 quarters · filed 2025-03-31 | $70.34M 10-K · filed 2025-03-31 |
| 2023-09-30 | $36.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $46.97M derived: sum of 2 quarters · filed 2024-11-14 | $64.66M 10-Q · filed 2024-11-14 | $77.24M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $10.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $28.34M 10-Q · filed 2024-08-01 | $40.92M derived: sum of 3 quarters · filed 2024-08-01 | $54.56M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $17.68M 10-Q · filed 2024-05-07 | $30.26M derived: sum of 2 quarters · filed 2024-05-07 | $43.91M derived: sum of 3 quarters · filed 2024-05-07 | $54.71M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $12.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $26.23M derived: sum of 2 quarters · filed 2024-02-08 | $37.03M derived: sum of 3 quarters · filed 2024-02-08 | $62.00M 10-K · filed 2024-02-08 |
| 2022-09-30 | $13.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $24.45M derived: sum of 2 quarters · filed 2023-11-02 | $49.42M 10-Q · filed 2023-11-02 | $71.57M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $10.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $35.77M 10-Q · filed 2023-08-03 | $57.92M derived: sum of 3 quarters · filed 2023-08-03 | $73.95M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $24.97M 10-Q · filed 2023-05-04 | $47.12M derived: sum of 2 quarters · filed 2023-05-04 | $63.15M derived: sum of 3 quarters · filed 2023-05-04 | $109.03M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $22.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $38.18M derived: sum of 2 quarters · filed 2023-03-13 | $84.05M derived: sum of 3 quarters · filed 2023-03-13 | $93.13M 10-K · filed 2023-03-13 |
| 2021-09-30 | $16.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $61.91M derived: sum of 2 quarters · filed 2022-11-09 | $70.98M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $45.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $54.95M 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $9.07M 10-Q · filed 2022-05-05 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $0.00 10-Q · filed 2021-08-03 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-12 | |||
| 2019-09-30 | $2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $10.91M 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | $8.02M 10-Q · filed 2020-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |